These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 35304257)
1. Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastoma. Zhu L; Yang Y; Li H; Xu L; You H; Liu Y; Liu Z; Liu X; Zheng D; Bie J; Li J; Song C; Yang B; Luo J; Chang Q Cancer Lett; 2022 Jun; 535():215630. PubMed ID: 35304257 [TBL] [Abstract][Full Text] [Related]
2. CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model. Tan IL; Arifa RDN; Rallapalli H; Kana V; Lao Z; Sanghrajka RM; Sumru Bayin N; Tanne A; Wojcinski A; Korshunov A; Bhardwaj N; Merad M; Turnbull DH; Lafaille JJ; Joyner AL Oncogene; 2021 Jan; 40(2):396-407. PubMed ID: 33159168 [TBL] [Abstract][Full Text] [Related]
3. Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality. Dang MT; Gonzalez MV; Gaonkar KS; Rathi KS; Young P; Arif S; Zhai L; Alam Z; Devalaraja S; To TKJ; Folkert IW; Raman P; Rokita JL; Martinez D; Taroni JN; Shapiro JA; Greene CS; Savonen C; Mafra F; Hakonarson H; Curran T; Haldar M Cell Rep; 2021 Mar; 34(13):108917. PubMed ID: 33789113 [TBL] [Abstract][Full Text] [Related]
4. LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes. Do AD; Wu KS; Chu SS; Giang LH; Lin YL; Chang CC; Wong TT; Hsieh CL; Sung SY J Exp Clin Cancer Res; 2024 Apr; 43(1):130. PubMed ID: 38689348 [TBL] [Abstract][Full Text] [Related]
5. Aggressive Medulloblastoma-Derived Exosomal miRNAs Promote In Vitro Invasion and Migration of Tumor Cells Via Ras/MAPK Pathway. Zhu LY; Wu XY; Liu XD; Zheng DF; Li HS; Yang B; Zhang J; Chang Q J Neuropathol Exp Neurol; 2020 Jul; 79(7):734-745. PubMed ID: 32417918 [TBL] [Abstract][Full Text] [Related]
6. A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma. Pak E; MacKenzie EL; Zhao X; Pazyra-Murphy MF; Park PMC; Wu L; Shaw DL; Addleson EC; Cayer SS; Lopez BG; Agar NYR; Rubin LL; Qi J; Merk DJ; Segal RA Neuro Oncol; 2019 Sep; 21(9):1150-1163. PubMed ID: 31111916 [TBL] [Abstract][Full Text] [Related]
7. Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis. Li Y; Song Q; Day BW Acta Neuropathol Commun; 2019 Jul; 7(1):123. PubMed ID: 31362788 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma. Rodriguez-Blanco J; Pednekar L; Penas C; Li B; Martin V; Long J; Lee E; Weiss WA; Rodriguez C; Mehrdad N; Nguyen DM; Ayad NG; Rai P; Capobianco AJ; Robbins DJ Oncogene; 2017 Nov; 36(45):6306-6314. PubMed ID: 28714964 [TBL] [Abstract][Full Text] [Related]
9. Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma. Purzner T; Purzner J; Buckstaff T; Cozza G; Gholamin S; Rusert JM; Hartl TA; Sanders J; Conley N; Ge X; Langan M; Ramaswamy V; Ellis L; Litzenburger U; Bolin S; Theruvath J; Nitta R; Qi L; Li XN; Li G; Taylor MD; Wechsler-Reya RJ; Pinna LA; Cho YJ; Fuller MT; Elias JE; Scott MP Sci Signal; 2018 Sep; 11(547):. PubMed ID: 30206138 [TBL] [Abstract][Full Text] [Related]
10. Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma. Tsiami F; Lago C; Pozza N; Piccioni F; Zhao X; Lülsberg F; Root DE; Tiberi L; Kool M; Schittenhelm J; Bandopadhayay P; Segal RA; Tabatabai G; Merk DJ Acta Neuropathol Commun; 2024 Aug; 12(1):125. PubMed ID: 39107797 [TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophages in SHH subgroup of medulloblastomas. Margol AS; Robison NJ; Gnanachandran J; Hung LT; Kennedy RJ; Vali M; Dhall G; Finlay JL; Erdreich-Epstein A; Krieger MD; Drissi R; Fouladi M; Gilles FH; Judkins AR; Sposto R; Asgharzadeh S Clin Cancer Res; 2015 Mar; 21(6):1457-65. PubMed ID: 25344580 [TBL] [Abstract][Full Text] [Related]
12. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Northcott PA; Fernandez-L A; Hagan JP; Ellison DW; Grajkowska W; Gillespie Y; Grundy R; Van Meter T; Rutka JT; Croce CM; Kenney AM; Taylor MD Cancer Res; 2009 Apr; 69(8):3249-55. PubMed ID: 19351822 [TBL] [Abstract][Full Text] [Related]
13. microRNA-155-3p delivered by M2 macrophages-derived exosomes enhances the progression of medulloblastoma through regulation of WDR82. Song L; Luan B; Xu Q; Shi R; Wang X J Transl Med; 2022 Jan; 20(1):13. PubMed ID: 34983581 [TBL] [Abstract][Full Text] [Related]
14. STAT3 is required for Smo-dependent signaling and mediates Smo-targeted treatment resistance and tumorigenesis in Shh medulloblastoma. Yuan L; Zhang H; Liu J; Malhotra A; Dey A; Yu B; Jella KK; McSwain LF; Schniederjan MJ; MacDonald TJ Mol Oncol; 2022 Feb; 16(4):1009-1025. PubMed ID: 34482626 [TBL] [Abstract][Full Text] [Related]
15. PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma. Singh AR; Joshi S; Zulcic M; Alcaraz M; Garlich JR; Morales GA; Cho YJ; Bao L; Levy ML; Newbury R; Malicki D; Messer K; Crawford J; Durden DL PLoS One; 2016; 11(3):e0150836. PubMed ID: 26938241 [TBL] [Abstract][Full Text] [Related]
16. Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032. Robinson GW; Orr BA; Wu G; Gururangan S; Lin T; Qaddoumi I; Packer RJ; Goldman S; Prados MD; Desjardins A; Chintagumpala M; Takebe N; Kaste SC; Rusch M; Allen SJ; Onar-Thomas A; Stewart CF; Fouladi M; Boyett JM; Gilbertson RJ; Curran T; Ellison DW; Gajjar A J Clin Oncol; 2015 Aug; 33(24):2646-54. PubMed ID: 26169613 [TBL] [Abstract][Full Text] [Related]
17. Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma. Brun SN; Markant SL; Esparza LA; Garcia G; Terry D; Huang JM; Pavlyukov MS; Li XN; Grant GA; Crawford JR; Levy ML; Conway EM; Smith LH; Nakano I; Berezov A; Greene MI; Wang Q; Wechsler-Reya RJ Oncogene; 2015 Jul; 34(29):3770-9. PubMed ID: 25241898 [TBL] [Abstract][Full Text] [Related]
18. Tenovin-6 exhibits inhibitory effects on the growth of Sonic Hedgehog (SHH) medulloblastoma, as evidenced by both in vitro and in vivo studies. Wang B; Xu T; Qiu C; Yu L; Xu S; Zhao X; Xu C; Tan F; Sheng H; Zhang N Int Immunopharmacol; 2024 Dec; 142(Pt A):113075. PubMed ID: 39260312 [TBL] [Abstract][Full Text] [Related]